IL1B and COVID-19: Unexpectedly, pro-inflammatory monocyte markers such as IL1B and TNF are downregulated in COVID-19 monocytes relative to controls (Supplementary Fig. 11), both in progressive and in stable patients, although IL1B was slightly less downregulated in stable patients.